Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
McKesson
Federal Trade Commission
Medtronic
Boehringer Ingelheim
Chinese Patent Office
Merck
Covington

Generated: August 15, 2018

US Patents for PCT: WO2004/060374


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Otsuka ABILIFY aripiprazole SOLUTION;ORAL 021713-001 Dec 10, 2004 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka ABILIFY aripiprazole TABLET, ORALLY DISINTEGRATING;ORAL 021729-002 Jun 7, 2006 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka ABILIFY aripiprazole TABLET, ORALLY DISINTEGRATING;ORAL 021729-003 Jun 7, 2006 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka ABILIFY aripiprazole TABLET;ORAL 021436-001 Nov 15, 2002 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka ABILIFY aripiprazole TABLET;ORAL 021436-002 Nov 15, 2002 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Otsuka ABILIFY aripiprazole TABLET;ORAL 021436-003 Nov 15, 2002 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ADJUNCTIVE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Fish and Richardson
Boehringer Ingelheim
McKinsey
AstraZeneca
QuintilesIMS
Cantor Fitzgerald
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.